New drug therapies offer promise to some hepatitis C sufferers whose transplanted livers are threated by a recurrence of the disease, including some patients who have had no treatment options. The encouraging findings are contained in two new studies by a collaboration of researchers across the…
Source:Studies of experimental hepatitis C drug show promise for preventing recurrence in liver transplant
Thursday, October 31, 2013
Studies of experimental hepatitis C drug show promise for preventing recurrence in liver transplant
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment